Navigation Links
ANGIO CT MIYABI

ProductsANGIO CT MIYABI
Company Siemens Medical Solutions USA, Inc.
Item ANGIO CT MIYABI
Features 
  • Interventional procedures (e.g. percutaneous biopsy of bone lesions, drainage of abscesses, nephrostomy)
  • Evaluation of the treatment extent during chemoembolisation of tumors
  • Targeted application of antiangiogenetic agents
  • Diagnostics and immediate treatment of strokes
  • Endovascular treatment of aneurysms
  • All features of the AXIOM Multistar angiography unit
  • Full functionality of the SOMATOM CT scanner
  • Movements of C-arm and CT gantry are controlled in the same spacial coordinates around the patient
Description The ANGIO CT MIYABI system is a combination of a Siemens SOMATOM CT scanner on rails (Sliding Gantry) and an AXIOM Multistar angiography unit. Both systems use the KOORDINAT M angio table, which can be switched between floating DSA position and fixed CT position.

During angiography, CT is located in the park position. When it is nesessary to confirm the target position in surrounding tissues, the gantry moves in less than 1 minute into its working position and scans the patient. All scan options such as sequence, spiral acquisition, or gantry tilt are available. Thus, you can always generate a control image during intervention without repositioning the patient.
Info Siemens Medical Solutions USA, Inc.
Customer Service: (888) 826-9702
Web site: http://www.usa.siemens.com/medical

Related medicine products :

1. ANGIOGUARD® Capture Guidewire
2. ANGIOGUARD Capture Guidewire
3. Angio-MR MIYABI
...lumn of a 384 Well Plate at Once , To increase ef...need a pipettor that can adapt to the narrow well ...annel Impact pipettor., Available with Impact or ...tion was specifically designed to allow you to tra...
EnTrust family of ICDs provides a suite of features for total AT/AF co-morbidity management, including diagnostics to detect when your patient develops AT/AF, and both termination and intervention th
...e world leader in peel-away introducers. Our peel-...pacemaker and defibrillator lead implantation, cen...r temporary pacemaker insertions. The advanced des...udes the Di-Lock™ locking dilator and offers...
...ary Self-Expanding Stent System combines low-profi...y in one system. This .018" guide wire compatible ...ter compatibility in all diameters (5.0 - 10.0 mm)....018 system is offered in five stent lengths (28, ...
Medicine Products:
(Date:5/16/2008)...e of Oral and Overall Health, HARRISBURG, Pa., Ma...d,Concordia Dental is celebrating National Smile M...and the British Dental Health Foundation to,promot... Beginning May 18,this year,s event is launching ... the largest independent international dental heal...
(Date:5/16/2008)...ociety of Clinical Oncology meeting in Chicago (Ab...out 25 percent of patients with colon cancer and i...ctal cancers will be staged. , This new study,...tion-based statistic registries from 1992 to 2004,...comes of patients with positive nodes (Stage III) ...
(Date:5/16/2008)...fit from calcitriol, an oral form , , FR...vitamin D may cut the risk of death for people wit...ut one quarter, a new study suggests. , During...se being treated with calcitriol, an oral form of ...th lowered by 26 percent when compared with those ...
(Date:5/16/2008)...g of the uterus (submucosal) are more likely to mo...embolization (UAE) but usually dont cause major co...udy included 49 patients with 140 fibroids who und...e study found that 39 of these were submucosal. Of...er UAE, said Sachit Verma, MD, lead author of the ...
Breaking Medicine News(10 mins):Health News:United Concordia Dental Celebrates National Smile Month 2Health News:Vitamin D Use Linked to Lower Mortality in Kidney Patients 2
... the growing problem of obesity in Australians by ...he study, published in the latest edition of The M...elp they wanted from their general practitioner (G... Levels of overweight and obesity in Australia ha...
...gricultural Research (ICAR) has announced the arri...loped by the High Security Animal// Disease Labora...ce in the whole of India that conducts tests for t...ector General Mangala Rai said, "Viral diseases, s...
...leagues, investigators from the Howard Hughes Medi... could help in identifying previously// unknown ge... The researchers by using a new technique, where i... which are present inside acute myeloid leukemia (...
...lowing a cardiac arrest at the work place, the emp... legal heirs// under the Workmen Compensation Act,...loyers' liability for compensation under Section 3...jit Pasayat and Justice L S Panta said "it has to ...
Other Medicine News:Health News:New Technique Identifies Unknown Genetic Mutations That Can Cause Cancer 2Health News:New Technique Identifies Unknown Genetic Mutations That Can Cause Cancer 3
(Date:5/15/2008)...May 15 /- Eisai Corporation of North,...cal data abstracts about,compounds in the company,...ical oncology research have been accepted for pres...n Society of Clinical Oncology (ASCO),taking plac... variety of abstracts on Eisai marketed products a...
(Date:5/15/2008)...al data highlight safety profile of BSI-201 in ..., BRISBANE, Calif., May 15 /- BiPar ... company developing novel cancer therapies,today ...itor, BSI-201, will,be presented at the 2008 Ameri... Chicago., Findings will be presented from the fi...
(Date:5/15/2008)...May 15 /- Cytopia Limited,(...s upcoming oral,presentation on CYT997 at the 2008...l Oncology (ASCO) will be accessible to the public...pm on Thursday 15 May (US EDT)., The oral present...ovel,cytotoxic and vascular disrupting agent, in p...
(Date:5/15/2008)...demonstrated in Blacks, Hispanics/Latinos, People ...ls, PARSIPPANY, N.J., May 15 /- Daii...ted at the American Society of,Hypertension,s Twen...New,Orleans demonstrated that the powerful combina...xomil) safely and effectively helped,patients acro...
Breaking Medicine Technology:Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 2Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 3Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 4Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 5Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 6Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 7Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 8BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7Stop 26 Shop Alerts Customers to Product Advisory by ConAgra Foods 3409 1Stop 26 Shop Alerts Customers to Product Advisory by ConAgra Foods 3409 2Doctors of Optometry Applaud New Law Requiring Eye Exams for Illinois Children 3404 1Doctors of Optometry Applaud New Law Requiring Eye Exams for Illinois Children 3404 2Doctors of Optometry Applaud New Law Requiring Eye Exams for Illinois Children 3404 3Doctors of Optometry Applaud New Law Requiring Eye Exams for Illinois Children 3404 4Those With Disabilities as Well as Aging Population Throughout Country Now Have Access to Thousands of Specialized Products 3400 1Those With Disabilities as Well as Aging Population Throughout Country Now Have Access to Thousands of Specialized Products 3400 2Rural Metro Board of Directors Meets With Accipiter Capital Management 3395 1Rural Metro Board of Directors Meets With Accipiter Capital Management 3395 2Rural Metro Board of Directors Meets With Accipiter Capital Management 3395 3
... Clinical Data Published at the American,Society o...June 04, 2007 /PRNewswire-FirstCall/ -- Pharmion,C...s Phase II,multi-center clinical study of Amrubic...acycline currently in development,for the treatmen...te favorable interim results in terms of response ...
...-Jun 4, 2007 - Copernicus Therapeutics,Inc. annou...klahoma,Health Sciences Center, led by Dr. Muna Na...Copernicus, DNA nanoparticles corrected,vision def.... These,findings were presented at the American So...tions in genes important in the biology,of vision ...
Other Medicine Technology:Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 2Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 3Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 4Vision Deficit in Retinitis Pigmentosa Mice Corrected with DNA,Nanoparticles 2